Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

NCT00006054 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

OTHER

Sponsor class

Conditions

Immunologic Deficiency Syndromes
Chediak-Higashi Syndrome
Common Variable Immunodeficiency
Graft Versus Host Disease
X-Linked Lymphoproliferative Syndrome
Familial Erythrophagocytic Lymphohistiocytosis
Hemophagocytic Lymphohistiocytosis
X-linked Agammaglobulinemia
Wiskott-Aldrich Syndrome
Chronic Granulomatous Disease
X-linked Hyper IgM Syndrome
Severe Combined Immunodeficiency
Leukocyte Adhesion Deficiency Syndrome
Virus-Associated Hemophagocytic Syndrome

Interventions

DRUG: anti-thymocyte globulin
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: etoposide
DRUG: methotrexate
DRUG: methylprednisolone
DRUG: prednisone
PROCEDURE: Allogeneic Bone Marrow Transplantation

Sponsor

Fairview University Medical Center